Back to dashboard
CommercialCoverageMedium impact

Fractional Carbon Dioxide (CO2) Laser Ablation Treatment of Hypertrophic Scars or Keloids for Functional Improvement

Blue Cross & Blue Shield of Mississippi·Dermatology, Plastic Surgery, General Surgery·Medical Policy
Effective date
May 1, 2024
We identified it
Jun 20, 2026
Days to comply

Summary

Blue Cross Blue Shield has classified fractional carbon dioxide (CO2) laser ablation treatment for hypertrophic scars or keloids for functional improvement as investigational and not covered. This affects specific CPT codes for fractional ablative laser treatments that will not be reimbursed.

Action Required

Action needed
Immediately: Billing team must update system to deny/not submit claims for CPT codes 0479T and 0480T as these are classified as investigational and non-covered services. Providers should be notified that fractional CO2 laser ablation for hypertrophic scars/keloids will not be reimbursed and patients must be informed of self-pay status before treatment.